Approximately 25 to 30 percent of the healthy population carries the staphylococcus aureus (staph) bacteria on skin or in nasal passages, while 1 percent carries the antibiotic-resistant MRSA strain.

Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial ...

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are resistant to multiple antibiotics and commonly cause skin infections that can lead to serious or life-threatening infection in other ...

During the COVID pandemic, methicillin-resistant Staphylococcus aureus (MRSA) infections in acute care hospitals rose steeply, despite a decrease of infections before the pandemic, the Society for ...

The history of antibiotic resistance in Staphylococcus aureus spans more than half a century. Methicillin-resistant S. aureus (MRSA) has emerged as an almost ubiquitous pathogen in both the community ...

Treatment options for an infection caused by staphylococcus bacteria depend on the type of infection you have, how severe it is, and where it’s located on or in your body. Staph can cause a variety of ...

Endocarditis can be a life threatening complication of MRSA in which the infection causes inflammation in the lining of the heart, and its valves and chambers. Methicillin-resistant Staphylococcus ...

Schraga [1] reports that antibiotic therapy is not indicated for methicillin-resistant Staphylococcus aureus (MRSA) cutaneous abscesses unless there is extensive cellulitis or evidence of systemic ...

Antibiotic resistance is becoming an accelerating crisis because of the overuse and misuse of antibiotics over many years.

Nearly 120,000 people contracted bloodstream staph infections in the United States in 2017, most of them in health care facilities – and nearly 20,000 died. Progress against the most dangerous ...